Back to the feed
In brief
On 25.06.2024, a person holding the function "Executive member of the board of directors / senior management" at Santhera Pharmaceuticals Holding AG disclosed a sale worth CHF 9’036 to SIX Exchange Regulation.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Santhera Pharmaceuticals Holding AG declared a "Sale" transaction on 25.06.2024.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date25.06.2024
Issuing companySanthera Pharmaceuticals Holding AG
ISINCH1276028821
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity1’057
Unit priceCHF 8.55
AmountCHF 9’036
ExchangeXSWX
Notification IDT1O6P00087
Other Santhera Pharmaceuticals Holding AG insider transactions
These figures aggregate public disclosures. They are not investment advice.